Cargando…

Early Molecular Stratification of High-risk Primary Biliary Cholangitis

High-risk primary biliary cholangitis (PBC), defined by inadequate response at one year to Ursodeoxycholic acid (UDCA), is associated with disease progression and liver transplantation. Stratifying high-risk patients early would facilitate improved approaches to care. Using long-term follow-up data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hardie, Claire, Green, Kile, Jopson, Laura, Millar, Ben, Innes, Barbara, Pagan, Sarah, Tiniakos, Dina, Dyson, Jessica, Haniffa, Muzlifah, Bigley, Venetia, Jones, David E, Brain, John, Walker, Lucy J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161439/ https://www.ncbi.nlm.nih.gov/pubmed/27913155 http://dx.doi.org/10.1016/j.ebiom.2016.11.021

Ejemplares similares

Risk Stratification in Primary Biliary Cholangitis
por: Martini, Francesco, et al.
Publicado: (2023)

Langerin-expressing dendritic cells in human tissues are related to CD1c(+) dendritic cells and distinct from Langerhans cells and CD141(high) XCR1(+) dendritic cells
por: Bigley, Venetia, et al.
Publicado: (2015)

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study
por: Jones, David E.J., et al.
Publicado: (2022)

Rapid Detection of Dendritic Cell and Monocyte Disorders Using CD4 as a Lineage Marker of the Human Peripheral Blood Antigen-Presenting Cell Compartment
por: Jardine, Laura, et al.
Publicado: (2013)

Bile acid receptor agonists in primary biliary cholangitis: Regulation of the cholangiocyte secretome and downstream T cell differentiation
por: Etherington, Rachel E., et al.
Publicado: (2019)

The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines
por: Hirschfield, Gideon M, et al.
Publicado: (2018)

The inter‐relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis
por: Dyson, J. K, et al.
Publicado: (2016)

Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?
por: Wetten, Aaron, et al.
Publicado: (2022)

Donor monocyte–derived macrophages promote human acute graft-versus-host disease
por: Jardine, Laura, et al.
Publicado: (2020)

Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis
por: Dyson, Jessica Katharine, et al.
Publicado: (2020)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Integrative bioinformatics analysis and experimental validation of key biomarkers for risk stratification in primary biliary cholangitis
por: Tian, Siyuan, et al.
Publicado: (2023)

Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison
por: Montali, Lorenzo, et al.
Publicado: (2021)

Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation
por: Haniffa, Muzlifah, et al.
Publicado: (2009)

Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports
por: Yacoub, Haythem, et al.
Publicado: (2023)

Widespread gaps in the quality of care for primary biliary cholangitis in UK
por: Sivakumar, Mathuri, et al.
Publicado: (2021)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

A Systematic Review of Patient‐Reported Outcomes in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Kim, Hannah P., et al.
Publicado: (2020)

Extrahepatic Manifestations of Primary Biliary Cholangitis
por: Chalifoux, Sara L, et al.
Publicado: (2017)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Current understanding of primary biliary cholangitis
por: Tanaka, Atsushi
Publicado: (2021)

Primary biliary cholangitis: pathogenic mechanisms
por: Prieto, Jesús, et al.
Publicado: (2021)

The Role of Epigenetics in Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Timing of biliary decompression for acute cholangitis
por: Yang, Jian, et al.
Publicado: (2023)

Predicting Risk in Primary Biliary Cholangitis
por: Cho, Eun Ju
Publicado: (2023)

Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Adam, Leonie, et al.
Publicado: (2018)

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
por: Park, Ji-Won, et al.
Publicado: (2022)

Biomarkers for primary biliary cholangitis: current perspectives
por: Kouroumalis, Elias, et al.
Publicado: (2018)

Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
por: Joshita, Satoru, et al.
Publicado: (2017)

New treatments/targets for primary biliary cholangitis
por: Corpechot, Christophe, et al.
Publicado: (2019)

Primary Biliary Cholangitis-associated Palmar Keratosis
por: Usami, Jun
Publicado: (2021)

Primary Biliary Cholangitis: A Case of Underdiagnosis
por: Garcês Soares, Sofia, et al.
Publicado: (2021)

Update on the Pharmacological Treatment of Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Primary biliary cholangitis: Epidemiology, prognosis, and treatment
por: Trivella, Juan, et al.
Publicado: (2023)

Sequence of events leading to primary biliary cholangitis
por: Lenci, Ilaria, et al.
Publicado: (2023)

External validation of the United Kingdom‐primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid
por: Cheung, Angela C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_26djtghcuf592m07l7kptahlso